标题
Fracture risk following intermission of osteoporosis therapy
作者
关键词
Atypical fracture, Bisphosphonates, Denosumab, Drug holiday
出版物
OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-06-07
DOI
10.1007/s00198-019-05002-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis
- (2018) Albrecht Werner Popp et al. CALCIFIED TISSUE INTERNATIONAL
- An Essential Warning
- (2018) Benjamin Z Leder JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate Drug Holiday and Fracture Risk: A Population-Based Cohort Study
- (2018) Annette L Adams et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density
- (2018) K. E. Naylor et al. OSTEOPOROSIS INTERNATIONAL
- Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
- (2017) Steven R Cummings et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases
- (2017) Athanasios D Anastasilakis et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
- (2017) Panagiotis Anagnostis et al. MATURITAS
- Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: a nationwide user-only cohort study including over 60,000 alendronate users
- (2017) P. A. Eiken et al. OSTEOPOROSIS INTERNATIONAL
- Observations following discontinuation of long-term denosumab therapy
- (2017) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk
- (2017) M. A. Mignot et al. OSTEOPOROSIS INTERNATIONAL
- Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
- (2017) M. B. Zanchetta et al. OSTEOPOROSIS INTERNATIONAL
- One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study
- (2017) C. Reyes et al. OSTEOPOROSIS INTERNATIONAL
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- UK clinical guideline for the prevention and treatment of osteoporosis
- (2017) J. Compston et al. Archives of Osteoporosis
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mortality After Atypical Femoral Fractures: A Cohort Study
- (2016) Mohammad Kharazmi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study
- (2016) Bo Abrahamsen et al. BMJ-British Medical Journal
- Risk of atypical femoral fracture during and after bisphosphonate use
- (2015) Jörg Schilcher et al. Acta Orthopaedica
- Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once-Yearly ZOL: HORIZON-PFT Extension Study
- (2015) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: A systematic review
- (2015) Kareeann S. F. Khow et al. Journal of Nutrition Health & Aging
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Bisphosphonate drug holidays: we reap what we sow
- (2015) S. L. Silverman et al. OSTEOPOROSIS INTERNATIONAL
- Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday
- (2015) L. H. R. Xu et al. OSTEOPOROSIS INTERNATIONAL
- The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study
- (2015) S. Papapoulos et al. OSTEOPOROSIS INTERNATIONAL
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years
- (2015) S. Ferrari et al. OSTEOPOROSIS INTERNATIONAL
- Effects of Up to 5 Years of Denosumab Treatment on Bone Histology and Histomorphometry: The FREEDOM Study Extension
- (2014) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus
- (2014) Aliya A Khan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?
- (2014) Felicia Cosman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Model of BMD Changes After Alendronate Discontinuation to Guide Postalendronate BMD Monitoring
- (2014) Brian McNabb et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA)
- (2014) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties
- (2014) N. Hassler et al. OSTEOPOROSIS INTERNATIONAL
- Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis
- (2014) E. Cairoli et al. OSTEOPOROSIS INTERNATIONAL
- Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy
- (2014) Douglas C. Bauer et al. JAMA Internal Medicine
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis: Executive Summary of Recommendations
- (2013) Nelson Watts et al. Endocrine Practice
- BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate
- (2013) Brian Louis McNabb et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension
- (2013) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy
- (2013) Chris Recknor et al. OBSTETRICS AND GYNECOLOGY
- Incidence of atypical nontraumatic diaphyseal fractures of the femur
- (2012) Richard M Dell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Discontinuation of denosumab and associated fracture incidence: Analysis from the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
- (2012) Jacques P Brown et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- Risk assessment of fragility fractures: summary of NICE guidance
- (2012) S. Rabar et al. BMJ-British Medical Journal
- Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension
- (2011) Socrates Papapoulos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Stopping Risedronate after Long-Term Treatment on Bone Turnover
- (2011) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
- (2011) Henry G. Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
- (2011) Jörg Schilcher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
- (2011) P. D. Miller et al. OSTEOPOROSIS INTERNATIONAL
- Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension
- (2011) G. Bianchi et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial
- (2010) Ann V Schwartz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research
- (2010) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone Turnover: Six-Year Results of a Phase 2 Clinical Trial
- (2010) Paul D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
- (2010) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risedronate reduces intracortical porosity in women with osteoporosis
- (2009) Babul Borah et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)
- (2009) P Roschger et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
- (2009) Joan C. Lo et al. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday
- (2008) J. R. Curtis et al. OSTEOPOROSIS INTERNATIONAL
- Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
- (2008) C. Roerholt et al. OSTEOPOROSIS INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now